403 related articles for article (PubMed ID: 33388969)
1. Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic.
Ahmed S; Gasparyan AY; Zimba O
Rheumatol Int; 2021 Feb; 41(2):243-256. PubMed ID: 33388969
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across-sectional study.
Zhang Y; Xu P; Huang J; Hu Z
Int J Rheum Dis; 2024 Apr; 27(4):e15150. PubMed ID: 38661306
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL
Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032
[TBL] [Abstract][Full Text] [Related]
4. Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
Nikiphorou E; Alpizar-Rodriguez D; Gastelum-Strozzi A; Buch M; Peláez-Ballestas I
Rheumatology (Oxford); 2021 May; 60(5):2040-2045. PubMed ID: 33496334
[TBL] [Abstract][Full Text] [Related]
5. Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study.
Nuñez DF; Leon L; Garcia AM; Arce JIC; Mucientes A; Gutierrez-Fernandez B; Rodriguez L; Cristóbal IPS; Álvarez P; Prada CM; Abasolo L
Ther Adv Musculoskelet Dis; 2022; 14():1759720X221090296. PubMed ID: 35510167
[TBL] [Abstract][Full Text] [Related]
6. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V
Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462
[TBL] [Abstract][Full Text] [Related]
7. The impact of the COVID-19 pandemic on people with rheumatic and musculoskeletal diseases: insights from patient-generated data on social media.
Reuter K; Deodhar A; Makri S; Zimmer M; Berenbaum F; Nikiphorou E
Rheumatology (Oxford); 2021 Oct; 60(SI):SI77-SI84. PubMed ID: 33629107
[TBL] [Abstract][Full Text] [Related]
8. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Plazuelo-Ramos P; Webb D; Jacklin C; Irwin S; Grange L; Makri S; Frazão Mateus E; Mingolla S; Antonopoulou K; Sanz-Gómez S; Correa-Fernández J; Carmona L; Navarro-Compán V
RMD Open; 2021 Apr; 7(1):. PubMed ID: 33827969
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V; Beltran-Aguilar VM; Arias-Peralta AG; De Avila-Gonzalez N; Guajardo-Jauregui N
Clin Rheumatol; 2023 Oct; 42(10):2677-2690. PubMed ID: 36627529
[TBL] [Abstract][Full Text] [Related]
10. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.
Conway R; Grimshaw AA; Konig MF; Putman M; Duarte-García A; Tseng LY; Cabrera DM; Chock YPE; Degirmenci HB; Duff E; Egeli BH; Graef ER; Gupta A; Harkins P; Hoyer BF; Jayatilleke A; Jin S; Kasia C; Khilnani A; Kilian A; Kim AHJ; Lin CMA; Low C; Proulx L; Sattui SE; Singh N; Sparks JA; Tam H; Ugarte-Gil MF; Ung N; Wang K; Wise LM; Yang Z; Young KJ; Liew JW; Grainger R; Wallace ZS; Hsieh E;
Arthritis Rheumatol; 2022 May; 74(5):766-775. PubMed ID: 34807517
[TBL] [Abstract][Full Text] [Related]
12. Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021.
Huang YT; Jenkins DA; Yimer BB; Benitez-Aurioles J; Peek N; Lunt M; Dixon WG; Jani M
Rheumatology (Oxford); 2024 Apr; 63(4):1093-1103. PubMed ID: 37432340
[TBL] [Abstract][Full Text] [Related]
13. African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.
Akintayo RO; Bahiri R; El Miedany Y; Olaosebikan H; Kalla AA; Adebajo AO; Migowa AN; Slimani S; Koussougbo OD; Kawther BA; Akpabio AA; Ghozlani I; Dey D; Hassan WA; Govind N; Makan K; Mohamed A; Genga EK; Ghassem MKA; Mortada M; Hamdi W; Wabi MO; Tikly M; Ngandeu-Singwe M; Scott C
Clin Rheumatol; 2021 Sep; 40(9):3445-3454. PubMed ID: 32876786
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L;
Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435
[TBL] [Abstract][Full Text] [Related]
15. 10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UK.
Jalali-Najafabadi F; Bailey R; Lyons J; Akbari A; Ba Dhafari T; Azadbakht N; Rafferty J; Watkins A; Martin GP; Bowes J; Lyons RA; Barton A; Peek N
BMJ Open; 2024 Jun; 14(6):e079169. PubMed ID: 38904124
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.
Lawson-Tovey S; Machado PM; Strangfeld A; Mateus E; Gossec L; Carmona L; Raffeiner B; Bulina I; Clemente D; Zepa J; Rodrigues AM; Mariette X; Hyrich KL;
RMD Open; 2022 Jul; 8(2):. PubMed ID: 35908834
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study.
Smith TO; Belderson P; Dainty JR; Birt L; Durrant K; Chipping JR; Tsigarides J; Yates M; Naughton F; Werry S; Notley C; Shepstone L; MacGregor AJ
BMJ Open; 2021 Jun; 11(6):e048772. PubMed ID: 34083347
[TBL] [Abstract][Full Text] [Related]
18. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
19. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
